We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
+11.03%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$60.9B
AUM Growth
+$2.53B
Cap. Flow
-$2.05B
Cap. Flow %
-3.37%
Top 10 Hldgs %
34.77%
Holding
1,731
New
34
Increased
253
Reduced
1,344
Closed
34

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$163M
2
FOUR icon
Shift4
FOUR
+$127M
3
TMO icon
Thermo Fisher Scientific
TMO
+$126M
4
ELF icon
e.l.f. Beauty
ELF
+$94.4M
5
KKR icon
KKR & Co
KKR
+$84.6M

Sector Composition

Rank Sector Weight
1 Technology 33.11%
2 Financials 12.96%
3 Healthcare 11.29%
4 Communication Services 9.96%
5 Consumer Discretionary 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTI icon
676
TechnipFMC
FTI
$29.1B
$3.45M 0.01%
87,485
-59,770
-41% -$2.19M
FAF icon
677
First American
FAF
$8.1B
$3.44M 0.01%
53,617
-33,380
-38% -$2.11M
UDR icon
678
UDR
UDR
$12.6B
$3.44M 0.01%
92,213
-30,245
-25% -$1.18M
CPT icon
679
Camden Property Trust
CPT
$11.5B
$3.41M 0.01%
31,941
-32,985
-51% -$3.62M
GEN icon
680
Gen Digital
GEN
$16.7B
$3.34M 0.01%
117,702
-70,900
-38% -$2.12M
OZK icon
681
Bank OZK
OZK
$5.6B
$3.32M 0.01%
65,097
+7,305
+13% +$373K
AMH icon
682
American Homes 4 Rent
AMH
$12.1B
$3.28M 0.01%
98,722
-33,125
-25% -$1.15M
ELDN icon
683
Eledon Pharmaceuticals
ELDN
$261M
$3.28M 0.01%
1,264,919
RIVN icon
684
Rivian
RIVN
$24B
$3.27M 0.01%
222,629
-396,905
-64% -$5.32M
PNFP icon
685
Pinnacle Financial Partners Inc
PNFP
$15.8B
$3.27M 0.01%
34,826
+4,365
+14% +$436K
CG icon
686
Carlyle Group
CG
$16.2B
$3.23M 0.01%
51,567
-13,725
-21% -$857K
L icon
687
Loews
L
$24.5B
$3.21M 0.01%
32,012
-17,900
-36% -$1.69M
MRNA icon
688
Moderna
MRNA
$21.8B
$3.21M 0.01%
124,175
+295
+0.2% +$8.23K
J icon
689
Jacobs Solutions
J
$16.2B
$3.2M 0.01%
21,364
-13,420
-39% -$1.93M
BNS icon
690
Scotiabank
BNS
$107B
$3.2M 0.01%
49,406
-23,300
-32% -$1.37M
TXRH icon
691
Texas Roadhouse
TXRH
$13.8B
$3.19M 0.01%
19,226
-11,295
-37% -$1.99M
LPX icon
692
Louisiana-Pacific
LPX
$5.21B
$3.18M 0.01%
35,812
-24,355
-40% -$2.25M
VIR icon
693
Vir Biotechnology
VIR
$1.46B
$3.17M 0.01%
554,981
-28,000
-5% -$143K
LOPE icon
694
Grand Canyon Education
LOPE
$4.15B
$3.17M 0.01%
14,428
+2,325
+19% +$447K
CM icon
695
Canadian Imperial Bank of Commerce
CM
$108B
$3.15M 0.01%
39,400
-17,700
-31% -$1.33M
DOW icon
696
Dow Inc
DOW
$21.5B
$3.14M 0.01%
136,963
+18,526
+16% +$462K
NEU icon
697
NewMarket
NEU
$7.11B
$3.13M 0.01%
3,774
+1,165
+45% +$897K
THC icon
698
Tenet Healthcare
THC
$22.4B
$3.1M 0.01%
15,277
-11,300
-43% -$2M
COO icon
699
Cooper Companies
COO
$14.2B
$3.08M 0.01%
44,944
-22,000
-33% -$1.56M
WSO icon
700
Watsco Inc
WSO
$12.8B
$3.07M 0.01%
7,602
-4,155
-35% -$1.78M

Similar funds

Ensign Peak Advisors's Q3 2025 Portfolio in Review

As of Q3 2025, Ensign Peak Advisors held 1,731 positions worth $60.9B, up 4.3% from $58.4B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Ensign Peak Advisors withdrew a net $2.05B in Q3 2025, closing 34 positions and reducing 1,344 holdings. Its most notable exit was WNS Holdings, an estimated $34M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Ensign Peak Advisors opened a new position in Heartflow Inc worth $21.1M.

  • Ensign Peak Advisors's largest Q3 2025 buy was Heartflow Inc: 625,812 shares worth $21.1M.
  • Ensign Peak Advisors added most to Amazon in Q3 2025, an estimated $163M increase.
  • Ensign Peak Advisors's biggest Q3 2025 reduction was Eli Lilly, cutting an estimated $181M.
  • Ensign Peak Advisors fully exited WNS Holdings in Q3 2025, selling an estimated $34M.
  • Ensign Peak Advisors's ten largest holdings make up 35% of its $60.9B portfolio in Q3 2025.
  • Ensign Peak Advisors opened 34 new positions and closed 34 in Q3 2025.
  • Ensign Peak Advisors's portfolio value rose 4.3% quarter-over-quarter to $60.9B.

Based on Ensign Peak Advisors's 13F filing for Q3 2025, filed 13 Nov 2025.